Literature DB >> 187763

Elevated adenosine 3',5'-cyclic monophosphate levels in human and animal tumors in vivo.

J P Minton, R H Matthews, T W Wisenbaugh.   

Abstract

Cyclic AMP (cAMP) levels were measured in several animal and human tumors and in normal human tissues. Malignant tissues did not appear to be deficient in cAMP.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 187763     DOI： 10.1093/jnci/57.1.39

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


  8 in total

Review 1.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

2.  Adverse effects of caffeine.

Authors:  A Darragh; M Kenny; R F Lambe; D A O'Kelly
Journal:  Ir J Med Sci       Date:  1981-02       Impact factor: 1.568

3.  Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development.

Authors:  E Israeli; B Raz; H Kerner; D Barzilai
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Prostaglandin E2 and cyclic AMP levels in human breast tumors.

Authors:  N Feller; T Malachi; I Halbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

5.  In vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts.

Authors:  G B Silberstein; P Strickland; V Trumpbour; S Coleman; C W Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients.

Authors:  T Malachi; C Chaimoff; N Feller; I Halbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

7.  Prostaglandin E2 and cyclic nucleotides in plasma and urine of colonic cancer patients.

Authors:  C Chaimoff; T Malachi; I Halbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

8.  Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.

Authors:  S R Li; Q Yang; E Wandl; W Pirker; I Virgolini
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.